Clinical Diagnosis of Some Viral  Human with Myocarditis Patients by PCR

Hawraa Dheyaa Rasool; Fadyia Mahdi Muslim Alameedy

Authors

Hawraa Dheyaa Rasool
hawraa.d.Rasool@jmu.edu.iq
Faculty of Pharmacy, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences, Al-Najaf, Iraq
Fadyia Mahdi Muslim Alameedy Professor, Department of Pathological Analysis Faculty of Science, Kufa University, Najaf, Iraq

Vol. 3 No. 8 (2025): International Journal of Integrative and Modern Medicine

Articles

August 3, 2025

Downloads

View Article

Abstract
How to Cite
Metrics
References

Three of Human samples from 100 samples of human Coxsakievirus, Adenovirus B1. Coronavirus were collected during October, 1st, 2021 to 8 of December 2021. Human Coxsakievirus, Adenovirus B1, Coronavirus were including (1month – 95 years). The qPCR method was detected of three samples, for sequence diagnosis the results showed Coxsakievirus (98.38%), Adenovirus B1 (95%), Coronavirus (80%) cases. The Population groups studied samples subject groups were distribution into (6) groups including (1month,1-15, 16-31 and 32-47 and 48-63 and 64-79 and 80-95) year, changed age too gender. The samples were isolated from the hospitals including (Al-Sadr, AL- Hakeem, AL- Sajjad). The first study in Iraq to diagnose of human Coxsakievirus, Adenovirus B1, Coronavirus with Myocarditis.

Rasool, H. D., & Alameedy, F. M. M. (2025). Clinical Diagnosis of Some Viral Human with Myocarditis Patients by PCR. International Journal of Integrative and Modern Medicine, 3(8), 1–6. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/2018

Download Citation

[1] G. Anja, H. Ahmet, H. Lisanne, K. Jens, and F. Henry, "Coxsackievirus B3—Its Potential as an Oncolytic Virus," Viruses, vol. 13, p. 718, 2021.

[2] Z. Han, Y. Zhang, K. He, J. Wang, H. Tang, Y. Sun, Q. Yang, D. Yang, S. Zhang, M. Yang, X. Wang, and W. Xu, "Two Coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide," BMC Infectious Diseases, vol. 19, p. 466, 2019.

[3] M. Scagnolari, L. Capobianchi, C. Trento, A. Bordi, C. Rozera, I. Ginevra, E. Galliano, L. Lalle, L. Ippolito, and A. Bartoloni, "Enteroviral Infections in the First Three Months of Life," Pathogens, vol. 11, p. 60, 2022.

[4] K. Shermila and K. Suresh, "Adenovirus Core Proteins: Structure and Function," Viruses, vol. 13, p. 388, 2021.

[5] A. Arnold and E. MacMahon, "Adenovirus infections," Medicine, 2017.

[6] R. Kaur, S. Sharma, G. Thakur, P. Singh, and J. Rani, "COVID-19: Pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination," Inflammopharmacology, 2022.

[7] B. Zhang, S. Kobayashi, A. Kuroda, and M. Fujita, "COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations," Journal of Medical Virology, vol. 93, pp. 2694–2704, 2021.

[8] A. Trzoska, K. Owczarek, A. Lasek, R. Mazur, M. Matusiak, A. Kowalczyk, A. Borawska, K. Jarzyna, G. Osuchowski, and M. Górny, "Myocarditis and inflammatory cardiomyopathy in 2021: an update," Polish Archives of Internal Medicine, vol. 131, no. 6, 2021.

[9] C. Loewe, E. Bonelli, E. Basha, N. Brunner, C. Pöttler, J. Hübler, K. Müller, and S. Aschauer, "Cardiovascular Magnetic Resonance in Myocarditis," Diagnostics, vol. 12, p. 399, 2022.

[10] I. Gdoura, S. Rachdi, R. Hamza, T. Huber, K. Boussetta, A. Ben Ahmed, S. Hachicha, and M. Abdellatif, "Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients," Molecular Medicine Reports, vol. 10, pp. 2811–2818, 2014.

[11] N. Eisenstein, J. Ni, D. Lee, M. Pankuweit, H.-P. Schultheiss, R. Morimoto, J. Hare, T. Bold, K. Rasmussen, and J. Aron, "Detection of Viruses in Myocardial Tissues by Polymerase Chain Reaction: Evidence of Adenovirus as a Common Cause of Myocarditis in Children and Adults," J. Am. Coll. Cardiol., vol. 42, no. 3, 2003.

[12] E. Kogan, Y. Bykov, O. Borisova, A. Kuznetsova, L. Sidorova, E. Golubev, and A. Emelyanov, "Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19," Diagnostic Pathology, vol. 17, p. 31, 2022.

[13] O. Valdés, B. Acosta, A. Pérez, C. Sánchez, A. González, G. Guerrero, G. González, L. Pérez, L. Silva, M. López, P. Álvarez, D. Rodríguez, V. Kourí, M. González, A. Lemos, I. Cuesta, and M. P. Pérez, "First Report on Fatal Myocarditis Associated With Adenovirus Infection in Cuba," Journal of Medical Virology, vol. 80, pp. 1756–1761, 2008.

[14] D. Egas, J. Jiménez, B. Palacios-Vélez, M. Barba, S. Maldonado, S. Chávez, J. Loor, F. Ramos, G. Escobar, M. García, V. Baque, P. Ruales-Salazar, and P. Castillo, "SARS-CoV-2 detection and sequencing in heart tissue associated with myocarditis and persistent arrhythmia: A case report," IDCases, vol. 25, p. e01187, 2021.

[15] F. M. M. Alameedy, "Sequences of S-surface of Human COVID-19," Journal of Pharmaceutical Research International, vol. 33, no. 60B, pp. 2572–2576, 2021.

[16] F. M. M. Alameedy, "Isolation and Molecular Study of Human Adenovirus," Proc. 2nd Int. Sci. Conf. Life Sciences, Faculty of Education for Women, University of Kufa, pp. 223–229, 2016.

[17] F. M. M. Alameedy et al., "Diagnosis of Human Coxsackievirus, Adenovirus and COVID-19 Virus Association Myocarditis by RT-PCR," Virology & Mycology, vol. 11, no. 6, pp. 1–4, 2022.

International Journal of Integrative and Modern Medicine

Clinical Diagnosis of Some Viral Human with Myocarditis Patients by PCR

Authors

Downloads

Similar Articles

submenu

counter